These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16996403)

  • 81. [Campylobacter jejuni enteritis and Guillain-Barre syndrome].
    Koga M; Yuki N
    Kansenshogaku Zasshi; 2003 Jun; 77(6):418-22. PubMed ID: 12872690
    [No Abstract]   [Full Text] [Related]  

  • 82. Detection of antibodies against Campylobacter jejuni serogroup PEN O:19 purified flagellar protein in a patient with Guillain-Barré syndrome.
    Lange D; Aleksic S; Kassubek J; Vrvic MM; Kist M; Steinbrückner B; Mitova M
    Zentralbl Bakteriol; 1999 Oct; 289(4):429-44. PubMed ID: 10603661
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.
    Hao Q; Saida T; Kuroki S; Nishimura M; Nukina M; Obayashi H; Saida K
    J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Intravenous immunoglobulin therapy for Guillain-Barré syndrome with IgG anti-GM1 antibody.
    Kuwabara S; Mori M; Ogawara K; Hattori T; Oda S; Koga M; Yuki N
    Muscle Nerve; 2001 Jan; 24(1):54-8. PubMed ID: 11150966
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
    Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N
    Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
    Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
    Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
    Ho TW; Mishu B; Li CY; Gao CY; Cornblath DR; Griffin JW; Asbury AK; Blaser MJ; McKhann GM
    Brain; 1995 Jun; 118 ( Pt 3)():597-605. PubMed ID: 7600081
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barré syndrome.
    Haifeng L
    Neurology; 2004 Nov; 63(10):1985; author reply 1985. PubMed ID: 15557541
    [No Abstract]   [Full Text] [Related]  

  • 89. A case-control study on children with Guillain-Barre syndrome in North China.
    Liu GF; Wu ZL; Wu HS; Wang QY; Zhao-Ri GT; Wang CY; Liang ZX; Cui SL; Zheng JD
    Biomed Environ Sci; 2003 Jun; 16(2):105-11. PubMed ID: 12964782
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Rare encounter of unilateral facial nerve palsy in an adolescent with Guillain-Barré syndrome.
    Iqbal M; Sharma P; Charadva C; Prasad M
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26823357
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
    Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
    Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom.
    Koga M; Yuki N; Hirata K
    J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):513-6. PubMed ID: 10201426
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice.
    Brooks PT; Brakel KA; Bell JA; Bejcek CE; Gilpin T; Brudvig JM; Mansfield LS
    Microbiome; 2017 Aug; 5(1):92. PubMed ID: 28789710
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain-Barré syndrome.
    Yuki N
    J Neurochem; 2007 Nov; 103 Suppl 1():150-8. PubMed ID: 17986150
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh.
    Islam Z; Jacobs BC; van Belkum A; Mohammad QD; Islam MB; Herbrink P; Diorditsa S; Luby SP; Talukder KA; Endtz HP
    Neurology; 2010 Feb; 74(7):581-7. PubMed ID: 20157160
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Guillain-Barré syndrome and Campylobacter jejuni: a serological study.
    Kaldor J; Speed BR
    Br Med J (Clin Res Ed); 1984 Jun; 288(6434):1867-70. PubMed ID: 6428580
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The relationship of Campylobacter jejuni infection and the development of Guillain-Barré syndrome.
    Tsang RS
    Curr Opin Infect Dis; 2002 Jun; 15(3):221-8. PubMed ID: 12015454
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a.
    Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
    Brain; 2000 Jan; 123 ( Pt 1)():116-24. PubMed ID: 10611126
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a patient with GVHD after allogeneic BMT.
    Hagensee ME; Benyunes M; Miller JA; Spach DH
    Bone Marrow Transplant; 1994 Mar; 13(3):349-51. PubMed ID: 8199580
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Long-term antibody responses following human infection with Campylobacter jejuni.
    Cawthraw SA; Feldman RA; Sayers AR; Newell DG
    Clin Exp Immunol; 2002 Oct; 130(1):101-6. PubMed ID: 12296859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.